You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Portable Cold Plasma System for Biowarfare Agent Decontamination
SBC: CFD RESEARCH CORPORATION Topic: CBD203003Biowarfare agents pose a significant threat to military personnel and operations and effective decontamination strategies are needed to mitigate risks associated with exposure. Traditional “wet” decontamination techniques utilize harsh chemicals (e.g. bleach) and are unsuitable for sensitive equipment (e.g. communications equipment). Plasmas consisting of ionized gases, radicals and free elect ...
SBIR Phase II 2022 Department of DefenseOffice for Chemical and Biological Defense -
Austere environment, durable, safe, glass equivalent auto injector container technology
SBC: SIO2 MEDICAL PRODUCTS INC Topic: CBD202003Autoinjectors are a critical piece of medical countermeasure equipment for the general public and our nation’s warfighters. Autoinjectors are used to deliver injectable drugs at home or in the field. Injectable drugs are typically packaged in traditional glass primary containers that are assembled into the auto-injector. Unfortunately, the glass autoinjector containers in use today are at risk o ...
SBIR Phase II 2022 Department of DefenseOffice for Chemical and Biological Defense -
Dermal Medical Countermeasures for Chemical Weapons Exposure
SBC: ZYMERON CORPORATION Topic: CBD161003The skin is the first line of defense against chemical warfare agents including nerve agents and toxic industrial chemicals, providing a possible barrier or delay to systemic distribution. Some chemicals also can act directly on the skin including the vesicants sulfur mustard and lewisite. Early and rapid skin decontamination is extremely important following exposure to CWAs and TICs because it de ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications
SBC: GENECAPTURE, INC. Topic: CBD15C001GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...
STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Hermetic Seals for Chemical/Biological Protective Garments
SBC: CREARE LLC Topic: CBD13109Interfaces on existing military chemical/biological protection garments are not designed to fully eliminate macroscopic and microscopic air gaps at folds, fabric surfaces, or hook-and-loop closures, and thus do not provide a hermetic barrier against exposure. Creare is developing hermetic garment closure systems that seal macroscopic and microscopic gaps at interfaces and closures and provide high ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense